OraSure Technologies Inc. - Form 8-K Summary
Business Context and Reporting Period
Company: OraSure Technologies, Inc.
Filing Date: October 20, 2004
Reporting Period: Current report for events occurring on October 20, 2004.
Business Context: The company is reporting a significant product launch and clinical trial update regarding its HIV testing capabilities.
Key Financial Metrics
This filing is a Current Report (Form 8-K) focused on specific corporate events. It does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for any financial performance indicators.
Material Changes
- Product Launch: The Company announced the launch of the OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test.
- Clinical Trial Update: The Company completed a previously announced assessment of a subset of data from an isolated clinical trial of the test using oral fluid samples.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99) detailing the launch and trial data assessment. No specific forward-looking guidance, financial outlook, or management commentary on future performance is included in the body of this 8-K text.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text beyond the standard nature of clinical trial assessments.
Investor Verification Checklist
- Review the attached press release (Exhibit 99) for specific details on the OraQuick® ADVANCE test launch.
- Verify the specific results of the "subset of data" from the isolated clinical trial mentioned in the filing.
- Confirm regulatory approval status and commercial availability timelines for the new test.
- Check subsequent filings for any financial impact or revenue recognition related to this product launch.